Market revenue in 2024 | USD 285.4 million |
Market revenue in 2030 | USD 335.2 million |
Growth rate | 2.7% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.85% in 2024. Horizon Databook has segmented the China hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
In China, the HAI diagnostics market is characterized by intense competition between global giants such as Roche and Abbott, and local manufacturers such as Mindray and Wondfo Biotech. The demand for molecular diagnostics has surged, driven by increasing hospital-acquired pneumonia cases and government initiatives promoting infection control.
International players are investing in local manufacturing facilities to enhance affordability and compliance with Chinese regulations, while domestic companies compete by offering cost-effective consumables and instruments.
In January 2024, China's National Health Commission announced the implementation of a new standard for monitoring hospital-acquired infections (HAIs), effective February 1st. These standard mandates comprehensive monitoring and reporting systems across all healthcare facilities, including hospitals, maternal and child health institutions, blood purification centers, specialized health institutions, emergency services, and nursing homes.
Horizon Databook provides a detailed overview of country-level data and insights on the China hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into China hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account